The Combination of Icotinib Hydrochloride and Fluzoparib Enhances the Radiosensitivity of Biliary Tract Cancer Cells

BACKGROUND: Radiotherapy and chemotherapy are the main clinical treatments for biliary tract cancers (BTCs). Patients with advanced disease have a very poor prognosis, yet no molecular targets have been proven effective for the adjuvant therapy of BTCs. In this study, we aimed to explore the effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Linggang, Zhu, Chu, Wang, Xuanxuan, Liu, Hai, Zhu, Yanhong, Sun, Xiaonan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682453/
https://www.ncbi.nlm.nih.gov/pubmed/33239915
http://dx.doi.org/10.2147/CMAR.S265327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682453/
https://www.ncbi.nlm.nih.gov/pubmed/33239915
http://dx.doi.org/10.2147/CMAR.S265327

Ejemplares similares